Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Preface
Volume: 20 Issue: 1
Author(s): Emilio Jirillo
Affiliation:
Export Options
About this article
Cite this article as:
Jirillo Emilio , Preface, Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20 (1) . https://dx.doi.org/10.2174/187153032001191213111933
DOI https://dx.doi.org/10.2174/187153032001191213111933 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women
Current Vascular Pharmacology Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
Current Drug Targets Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Mechanisms of Male Infertility: Role of Antioxidants
Current Drug Metabolism Metabolic Control and Diabetic Retinopathy
Current Diabetes Reviews Vitamin D Deficiency, Prevalence and Treatment in Neonatal Period
Endocrine, Metabolic & Immune Disorders - Drug Targets Structural Insight Into the Crucial Role of Ligand Chirality in the Activation of PPARs by Crystallographic Methods
Current Topics in Medicinal Chemistry T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets HSF1 as a Cancer Biomarker and Therapeutic Target
Current Cancer Drug Targets Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Engineered Bone Tissue with Naturally-Derived Small Molecules
Current Pharmaceutical Design Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer
Current Cancer Drug Targets The Contribution of Oxazolidinone Frame to The Biological Activity of Pharmaceutical Drugs and Natural Products
Mini-Reviews in Medicinal Chemistry Variability in Threshold for Medication Error Reporting Between Physicians, Nurses, Pharmacists, and Families
Current Drug Safety Ticagrelor: A Novel Drug for an Old Problem
Recent Patents on Cardiovascular Drug Discovery TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Current Drug Targets Use Of External Intrathecal Infusion Pumps In The Management Of Septic Complications: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effect of Stem Cell Transplantation Therapy for Post Viral Chronic Liver Cell Failure on Associated Type II Diabetes Mellitus: A Pilot Study
Endocrine, Metabolic & Immune Disorders - Drug Targets